(Q34123689)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20049424%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

title

Cerebral atrophy as outcome measure in short-term phase 2 clinical trials in multiple sclerosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20049424%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

main subject

phase II clinical trial

0 references

0 references

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20049424%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Massimo Filippi

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20049424%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

author name string

I J van den Elskamp

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20049424%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

B Boden

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20049424%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

D L Knol

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20049424%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

L Kappos

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20049424%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

K Wagner

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20049424%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

C Pohl

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20049424%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

R Sandbrink

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20049424%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

C H Polman

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20049424%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

B M J Uitdehaag

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20049424%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

F Barkhof

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20049424%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

F Fazekas

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20049424%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

publication date

5 January 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20049424%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20049424%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

volume

52

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20049424%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20049424%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

page(s)

875-881

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20049424%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00234-009-0645-1

16 January 2020

exact match

0 references

cites work

Sample sizes for brain atrophy outcomes in trials for secondary progressive multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2938443

Whole-brain T1 mapping in multiple sclerosis: global changes of normal-appearing gray and white matter.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2938443

The measurement and clinical relevance of brain atrophy in multiple sclerosis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2938443

Atrophy is detectable within a 3-month period in untreated patients with active relapsing remitting multiple sclerosis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2938443

Longitudinal brain volume measurement in multiple sclerosis: rate of brain atrophy is independent of the disease subtype.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2938443

Axonal loss in multiple sclerosis lesions: magnetic resonance imaging insights into substrates of disability

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2938443

Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis. US National MS Society Task Force.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2938443

Persistent T1 hypointensity as an MRI marker for treatment efficacy in multiple sclerosis.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2938443

Detecting treatment effects on brain atrophy in relapsing remitting multiple sclerosis: sample size estimates

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2938443

Determinants of cerebral atrophy rate at the time of diagnosis of multiple sclerosis.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2938443

Combining short interval MRI in Alzheimer's disease: Implications for therapeutic trials.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2938443

Oral interferon beta-1a in relapsing-remitting multiple sclerosis: a double-blind randomized study

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2938443

MR correlates of cerebral atrophy in patients with multiple sclerosis.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2938443

MRI brain volume changes in relapsing-remitting multiple sclerosis patients treated with interferon beta-1a.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2938443

Short-term brain volume change in relapsing-remitting multiple sclerosis: effect of glatiramer acetate and implications

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2938443

Normalized accurate measurement of longitudinal brain change.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2938443

Brain atrophy in relapsing-remitting multiple sclerosis: relationship with 'black holes', disease duration and clinical disability.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2938443

Progressive cerebral atrophy in MS: a serial study using registered, volumetric MRI

28 October 2018

1 reference

12 December 2020

Relationship between brain atrophy and disability: an 8-year follow-up study of multiple sclerosis patients

1 reference

12 December 2020

Short-term brain atrophy changes in relapsing–remitting multiple sclerosis

1 reference

12 December 2020

Use of the brain parenchymal fraction to measure whole brain atrophy in relapsing-remitting MS. Multiple Sclerosis Collaborative Research Group

1 reference

12 December 2020

10.1007/S00234-009-0645-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20049424%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

16 January 2020

1042748477

0 references

Fatcat ID

release_2jwtjkdg4vbkroucl5jfk3thui

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/2jwtjkdg4vbkroucl5jfk3thui

24 November 2022

mapped directly with Wikidata item

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20049424%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

PubMed publication ID

20049424

1 reference